ResMed News Breakdown

RMD -- USA Stock  

USD 102.69  0.56  0.54%

Macroaxis does not monitor all media channels or aggregates social signals for ResMed. But even though we do not provide professional-grade financial sentiment analysis on ResMed, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for ResMed. Additionally take a look at ResMed Hype Analysis, ResMed Correlation and ResMed Performance.
  
few hours ago at www.macroaxis.com         
Exercise or conversion by Rob Douglas of 5833 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
a day ago at www.macroaxis.com         
Sale by Michael Farrell of 5975 shares of ResMed
Macroaxis News
Filed transaction by Resmed Inc officer. General open market or private sale of non-derivative or derivative security
  
  
few days ago at www.macroaxis.com         
Exercise or conversion by David Pendarvis of 5000 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
few days ago at richlandstandard.com         
ResMed Inc -DI Recorded Above DI on These Shares
news
Richland Standard Get full coverage
  
  
over a week ago at www.macroaxis.com         
Exercise or conversion by Michael Farrell of 3200 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
over a week ago at www.macroaxis.com         
Exercise or conversion by David Pendarvis of 15 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
over a week ago at www.macroaxis.com         
Sale by David Pendarvis of 6364 shares of ResMed
Macroaxis News
Filed transaction by Resmed Inc officer. General open market or private sale of non-derivative or derivative security
  
  
over a week ago at cardinalweekly.com         
Exercise or conversion by Gallahue Kieran of 20000 shares of ResMed subject to Rule 16b-3
news
Filed transaction by Resmed Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
over a week ago at www.twst.com         
Exercise or conversion by David Pendarvis of 2810 shares of ResMed subject to Rule 16b-3
Twst News
Filed transaction by Resmed Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
over a week ago at nysedaily.com         
Sale by Hollingshead James of 600 shares of ResMed
news
Filed transaction by Resmed Inc officer. General open market or private sale of non-derivative or derivative security
  
  
over a week ago at www.macroaxis.com         
Exercise or conversion by Rich Sulpizio of 24390 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
over two weeks ago at www.macroaxis.com         
ResMed exotic insider transaction detected
Macroaxis News
Filed transaction by Resmed Inc director. Unconventional Insider trading
  
  
over two weeks ago at www.macroaxis.com         
ResMed exotic insider transaction detected
Macroaxis News
Filed transaction by Resmed Inc director. Unconventional Insider trading
  
  
over two weeks ago at www.macroaxis.com         
Sale by Rob Douglas of 500 shares of ResMed
Macroaxis News
Filed transaction by Resmed Inc officer. General open market or private sale of non-derivative or derivative security
  
  
over two weeks ago at www.macroaxis.com         
Exercise or conversion by Rich Sulpizio of 36000 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  

Build Optimal Portfolios

Diversify Your Portfolio With ResMed

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add ResMed to your portfolio

Investors are also looking into

Purchase by Harbinger Capital Partners Master Fund I Ltd of 181900 shares of Pyxus International
October 17, 2018 for Harbinger Capital Partners Master Fund I Ltd
Insteel Industries exotic insider transaction detected
October 17, 2018 for H Woltz
Sale by Blum Capital Partners Lp of 30200 shares of ITT Educational
October 17, 2018 for Blum Capital Partners Lp
View All Premium Stories  

ResMed Performance

Performance against DOW

 Price Growth (%)  
      Timeline 
1
Payment of 6309 shares by Rob Douglas of ResMed subject to R...09/27/2018
Additionally take a look at ResMed Hype Analysis, ResMed Correlation and ResMed Performance. Please also try Cryptocurrency Arbitrage module to find pairs of digital assets on multiple exchanges that are traded at a risk free arbitrage.
Search macroaxis.com